Geneva, March 31 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120900) titled 'A Study on Predicting the Therapeutic Response to Neoadjuvant Therapy for Non-Small Cell Lung Cancer Based on Artificial Intelligence Models' on March 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The First Affiliated Hospital of Nanchang University
Condition:
Non-small cell lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-25
Target Sample Size: Observation Group:400;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307606
Published by HT Digital Content Services with permi...